31st Annual Pharmaceutical / Chemical Patent Practice Update
The tradition continues for the annual Pharmaceutical/Chemical Practice Seminar, back for its 31st Year! Come hear practice tips, guidance, legal updates and summaries from leading experts. The program will encompass a variety of cutting edge topics, including patent eligibility, inherent obviousness, criteria for injunctions, launch at risk, and inequitable conduct.
In addition to earning valuable CLE credits (and Ethics CLE), your program registration includes lunch, starting at noon, and two breaks, which are great opportunities to network with your fellow program participants and NJIPLA members.
CLE: All credits are pending confirmation. New Jersey & New York 4.5 Credits, including 1.0 Ethics CreditsPennsylvania 4.0 Credits, including 1.0 Ethics Credits
Topics and Speakers:
Patent Eligibility for Diagnostic Methods, Natural Products and Biotech Inventions Post-Myriad
Criteria for Preliminary and Permanent Injunctions for Pharma and Biotech Cases: A Survey of Jurisdictions Worldwide
Recent Developments in Inequitable Conduct Law: Will Regeneron v. Merus Create a New Plague?